---
id: 20260306-T0-17
title: "Mozi框架规范药物发现LLM代理"
title_en: "Mozi Framework Standardizes Drug Discovery LLM Agents"
url: https://ai.daily.yangsir.net/daily/20260306-T0-17
issue_date: 2026-03-06
publish_date: 2026-03-05T05:00:00.000Z
source_name: "arXiv cs.AI"
source_url: https://arxiv.org/abs/2603.03655
---

# Mozi框架规范药物发现LLM代理

arXiv论文（编号2603.03655）发布Mozi框架，为药物发现领域的LLM代理提供受控自主能力。该框架解决工具使用治理和推理可靠性两大瓶颈。在分子生成任务中，Mozi产生的有效分子结构比无约束代理高3倍，且完全符合药物开发规范。制药公司可利用此框架加速药物发现流程，缩短研发周期。

## English Version

**Mozi Framework Standardizes Drug Discovery LLM Agents**

arXiv paper 2603.03655 introduces the Mozi framework, providing controlled autonomy for LLM agents in drug discovery. It addresses tool governance and reliability bottlenecks. Mozi generates 3x more valid molecular structures than unconstrained agents while complying with pharmaceutical standards. Pharmaceutical companies can use this framework to accelerate drug discovery and shorten R&D cycles.

---

**来源**：[arXiv cs.AI](https://arxiv.org/abs/2603.03655)

**详情页**：https://ai.daily.yangsir.net/daily/20260306-T0-17

---

*智语观潮 · Daily — https://ai.daily.yangsir.net/llms.txt*